You are here

  • Home
  • Archive
  • Volume 9, Issue 2
  • Review: adjuvant corticosteroid therapy reduces death, hearing loss, and neurological sequelae in bacterial meningitis

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: adjuvant corticosteroid therapy reduces death, hearing loss, and neurological sequelae in bacterial meningitis

https://doi.org/10.1136/ebm.9.2.48

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    van de Beek D, de Gans J, McIntyre P, et al. Corticosteroids in acute bacterial meningitis. Cochrane Database Syst Rev 2003;(3):CD004305.

    
 
 Q In children and adults with acute bacterial meningitis (ABM), is adjuvant corticosteroid therapy more effective than placebo for reducing mortality, hearing loss, and neurological sequelae?

    Clinical impact ratings IM/Ambulatory care ★★★★★☆☆ Internal medicine ★★★★★☆☆ Neurology ★★★★★★☆ Infectious disease ★★★★★☆☆

    METHODS

    Embedded ImageData sources

    studies were identified by searching the Cochrane Central Register of Controlled Trials (2003), Medline (1966 to January 2003), EMBASE/Excerpta Medica (1974 to April 2002), and Healthline (1988 to April 2002); reviewing current trials published before April 2002; scanning reference lists; hand searching abstracts of congresses; and contacting researchers and experts.

    Embedded ImageStudy selection and assessment

    studies in any language were selected if they were randomised controlled trials that compared any type of corticosteroid therapy adjuvant to antibiotics with placebo in patients with ABM and recorded case fatality rates. 2 reviewers independently assessed the quality of …

    View Full Text

    Footnotes

    • For correspondence: Dr D van de Beek, University of Amsterdam, The Netherlands. d.vandebeekamc.uva.nl

    • Source of funding: no external funding.